Journal
The British Journal of Psychiatry
Publication Date
11-1-2025
Volume
227
Issue
5
First Page
790
Last Page
797
Document Type
Open Access Publication
DOI
10.1192/bjp.2025.125
Rights and Permissions
Kim HK, Karp JF, Lavretsky H, Blumberger DM, Brown PJ, Flint AJ, Lenard E, Miller JP, Reynolds CF, Roose SP, Lenze EJ, Mulsant BH. Moderators of antidepressant augmentation versus switch in the OPTIMUM randomised controlled trial. Br J Psychiatry. 2025 Nov;227(5):790-797. doi: 10.1192/bjp.2025.125. Epub 2025 Jun 19 This is an Open Access article, distributed under the terms of the Creative Commons Attribution licence (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted re-use, distribution and reproduction, provided the original article is properly cited. © The Author(s), 2025. Published by Cambridge University Press on behalf of Royal College of Psychiatrists
Recommended Citation
Kim, Helena K; Karp, Jordan F; Lavretsky, Helen; Blumberger, Daniel M; Brown, Patrick J; Flint, Alastair J; Lenard, Emily; Miller, J Philip; Reynolds, Charles F; Roose, Steven P; Lenze, Eric J; and Mulsant, Benoit H, "Moderators of antidepressant augmentation versus switch in the OPTIMUM randomised controlled trial." The British Journal of Psychiatry. 227, 5. 790 - 797. (2025).
https://digitalcommons.wustl.edu/oa_4/7311
Department
ICTS (Institute of Clinical and Translational Sciences)
